Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Resilience and Eli Lilly Expand Partnership with $750 Million Investment to Boost U.S. Medicine Supply.
Jul 30, 2026•10 days ago
Contract Type
partnership
Description
Resilience has expanded its partnership with Eli Lilly and Company to enhance U.S. production of critical medicines with a $750 million investment. This expansion will include additional production capabilities for Lilly’s KwikPen device and is expected to create at least 400 new jobs in Ohio.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months